Sirona Biochem Corp V.SBM

morning star ratings

[thacker786]

Analyst Research and Ratings

SBM has outperformed its Biotechnology & Drugs peers over the last three months and over the past year.

Morningstar's Take

Morningstar's Take

Morningstar Rating	3 stars out of 5 starsQ
Quantitative Valuation	Undervalued
Fair ValueQ	0.87 CAD
Last price as of Oct 28, 2019	0.47 CAD
Quantitative Uncertainty	Very High
Economic Moat	--
Market Cap	103.1 M
Country of Domicile	Canada

Technical Summary Score

Short-Term Sentiment 

 

Recent bearish events outweigh bullish events. Bearish EvidenceRecent bearish events outweigh bullish events.

More information about Short-Term Sentiment.

Intermediate-Term Sentiment 

 

Recent bearish events outweigh bullish events. Very Strong Bearish EvidenceRecent bearish events outweigh bullish events.

More information about Intermediate-Term Sentiment.

Long-Term Sentiment 

 

All events are bearish. Bearish EvidenceAll events are bearish.

More information about Long-Term Sentiment.

Street Consensus

There is no data available.

Thomson Reuters Street Consensus

Street Consensus	-- / --

Strong Sell

 

Strong Buy

54321

---

View More Research

Top Industry Peer Comparison by Market Cap

	Symbol	Company Name	Market Cap	52 Week Range	Morningstar Rating	1 Year Performance(%)
	EDT	Spectral Medical Inc	108.4 M	0.20 - 0.50	3 stars out of 5 starsMorningstar Rating: 3 stars	+78.18
	SBM	Sirona Biochem Corp	104.1 M	0.065 - 0.69	3 stars out of 5 starsMorningstar Rating: 3 stars	+435.29
	ARCH	Arch Biopartners Inc	59.7 M	0.92 - 1.50	3 stars out of 5 starsMorningstar Rating: 3 stars	-32.19
	PMN	Promis Neurosciences Inc	54.9 M	0.18 - 0.44	3 stars out of 5 starsMorningstar Rating: 3 stars	-12.50
	NVH	Novoheart Holdings Inc	52.8 M	0.21 - 0.49	3 stars out of 5 starsMorningstar Rating: 3 stars	-20.00
	DMAC	DiaMedica Therapeutics Inc	48.1 M	1.70 - 7.36	3 stars out of 5 starsMorningstar Rating: 3 stars	-53.83
	SZLS	StageZero Life Sciences Inc	20.6 M	0.025 - 0.205	4 stars out of 5 starsMorningstar Rating: 4 stars	+77.78

Third-party investment research is available in English only.

© 2019  Click Here for Limitations and Restrictions on Use.

© 2019 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

Morningstar RatingTM The Morningstar RatingTM for funds, or "star rating", is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar RiskAdjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36- 59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods.

© 2019 Trading Central. All Rights Reserved. The information contained herein: (1) is proprietary to Trading Central and/or its content providers; (2) may not be copied or distributed; (3) is not warranted to be accurate, complete or timely; and, (4) does not constitute advice or a recommendation by RBC Direct Investing, Trading Central or its content providers in respect of the investment in financial instruments. Neither RBC Direct Investing nor Trading Central nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

Technical Event® is a registered trademark of Trading Central.

Trading Central products and services are protected under U.S. Patent Nos.: 6,801,201; 7,469,226; 7,469,238; 7,835,966; and 7,853,506; and corresponding foreign patents
 

As your agreement for the receipt and use of market data provides, the securities markets (1) reserve all rights to the market data that they make available, (2) do not guarantee that data; and (3) shall not be liable for any loss due either to their negligence or to any cause beyond their reasonable control. Also note that NYMEX and/or COMEX data is 10 minutes delayed.